Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles in Patients With Coronariopathies
- Conditions
- PeriodontitisCoronariopathy
- Interventions
- Procedure: Periodontal treatment
- Registration Number
- NCT02150005
- Lead Sponsor
- Universidade Veiga de Almeida
- Brief Summary
Objective: The aim of this study was to examine the effects of non-surgical periodontal treatment on the hemogram, glycemic and lipid profiles in cardiopathic patients with an indication for surgical revascularization.
Materials and Methods: Twenty-two patients with chronic periodontitis, over 35 years of age (mean age 59.45 years) randomly assigned into 2 groups were evaluated. Test group (n=11), received periodontal treatment before the surgical procedure, and control group (n=11), did not received periodontal treatment prior to surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 22
- Undergoing cardiovascular treatment;
- Eight viable teeth in the oral cavity;
- Four periodontal sites with periodontal probing depths ≥5mm in different teeth.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Periodontal treatment Periodontal treatment The test group received oral hygiene instructions, supragingival and subgingival scaling and root planning using curettes and an ultrasonic appliance.
- Primary Outcome Measures
Name Time Method Reduction in probing depth in sites with PPD>5mm Baseline and 90 days after the initial exam Reduction of 6.3% in probing depth in sites with Periodontal Probing Depth\>5mm
Reduction in probing depth in sites with PPD>3mm Baseline and 90 days after the initial exam Reduction of 11.4% in probing depth in sites with Periodontal Probing Depth\>3mm
Reduction in probing depth in sites with CAL>3mm Baseline and 90 days after the initial exam Reduction of 4.6% in probing depth in sites with Clinical Attachment Level \>3mm.
Reduction in probing depth in sites with CAL >5mm Baseline and 90 days after the initial exam Reduction of 3.6% in probing depth in sites with Clinical Attachment Level \>5mm.
Leukocyte count Baseline and 90 days after the initial exam Non-significant reduction of leukocyte count in the test group. Mean difference of 74.6 m/mcL.
Glucose Baseline and 90 days after the initial exam Glucose showed a non-significant increase in the test group. Mean difference of 24.2 mg/dL.
Hemocyte Baseline and 90 days after initial exam Hemocyte presented a non-significant reduction in the test group. Mean difference 0.39 m/mcL
Hemoglobin Baseline and 90 days after initial exam Non-significant reduction in test group. Mean difference of 0.2 g/dL
Total Cholesterol Baseline and 90 days after initial exam Significant reduction in the test group. Mean reduction of 27.4 mg/dL.
High density lipid Baseline and 90 days after initial exam Significant reduction in test group. Mean difference of 8.2 mg/dL.
Low density lipid Baseline and 90 days after initial exam Non-significant reduction in test group. Mean difference of 8.9 mg/dL.
- Secondary Outcome Measures
Name Time Method